Effect of Aerosolised Colistin in Ventilator Associated Pneumonia

PHASE4CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Pneumonia, Ventilator-Associated
Interventions
DRUG

"AS colistin and imipenem"

colimycin (colistin) powder (1 million units (MU) by flakon) by AS route in addition to imipenem

DRUG

"IV colistin and imipenem ."

colimycin (colistin) powder (1 MU by flakon) by intravenous route in addition to imipenem

DRUG

AS colimycin (colistin)

nebulisation of colimycin (colistin) for 30 minutes 3 times per day during at least 14 days. Nebulisation was made via an ultrasonic vibrating plates nebulizer (Aeroneb Pro® Aerogen Nektar Corporation, Galway, Ireland).

DRUG

IV colimycin (colistin)

intravenous colimycin (colistin) : 9 MU during 60 minutes followed by 4.5 million units 2 times per day

DRUG

AS colistin and imipenem

IV imipenem 1 g three times per day.

DRUG

IV colistin and imipenem

IV imipenem 1 g three times per day

Trial Locations (1)

1007

intensive care unit of the University Hospital Center La Rabta, Tunis

All Listed Sponsors
lead

Tunis University

OTHER

NCT02683603 - Effect of Aerosolised Colistin in Ventilator Associated Pneumonia | Biotech Hunter | Biotech Hunter